| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |